SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its recent surge, reportedly driven by AI/robotics sector sympathy and a potentially low float. Community members are actively discussing its volatile price action, with some anticipating further upward movement and a possible short squeeze, while others advise caution and profit-taking due to the stock's speculative nature.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's stock is trending due to upcoming 2026 guidance announcements and discussions around potential investment strategies, with some community members suggesting share buybacks or focusing on its pipeline. The stock's technicals and defensive qualities are also being debated, as is its potential in the weight loss drug market following recent deals. Community members are also actively discussing potential impacts on the company from recent reports related to COVID vaccines.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as investors eye the broader space sector amid news of a potential SpaceX IPO in 2026, with some seeing RKLB as an undervalued play compared to SpaceX. Community members are discussing long-term potential and strategic positioning, while also monitoring technical indicators and potential pullbacks after recent gains. Some are suggesting $RKLB could rally due to its position as a competitor in space systems.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending as investors discuss the stock's high short interest and potential for a squeeze, with some highlighting recent partnerships and long-term growth prospects in GaN technology. Community members are debating its valuation and relationship with NVDA, as well as its potential to capitalize on the growing AI data center market. Despite recent positive news, the stock's price action and trading volume are being closely watched for signs of a breakout.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending due to discussions surrounding its REZOLVE-AA Phase 2b study results for alopecia areata, with a focus on SALT score reductions and the drug's safety profile. Community sentiment is mixed, with some expressing concerns about statistical significance and potential outcomes, while others are optimistic about the upcoming conference call and potential buyout. The broader context involves comparisons to JAK inhibitors and anticipation of Phase 3 development in the treatment of severe-to-very-severe alopecia areata.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending amid news of autonomous driving tests in Austin, fueling community excitement about robotaxi potential; some analysts are upgrading their price targets, while others express caution. Discussions revolve around the company's leadership in autonomy and AI, countered by concerns about valuation and competition. The stock's recent performance and high trading volume are also driving conversation.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company’s website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

ROKU is trending following an upgrade from Morgan Stanley, with the community discussing the potential for new 52-week highs as analysts point to accelerating platform revenue growth and industry tailwinds. Some traders are expressing caution, noting selective participation and the stock's history of fading gains, while others are optimistic about further upside and potential short squeezes. Broader conversations touch on streaming wars, ad spend trends, and potential acquisitions.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as investors digest mixed signals from economic data, including rising unemployment coupled with job additions and soft retail sales, leading to a tug-of-war between bullish and bearish sentiments. Community members are debating the implications for future rate cuts and the overall health of the economy, with some anticipating a recession while others see a bear trap. The ETF's movements are further influenced by speculation around the Federal Reserve's next actions and potential market manipulation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending amid discussions about its valuation, potential for growth in the AI infrastructure space, and recent market volatility impacting data center stocks. Community members are debating whether it is oversold or still overvalued, while closely monitoring Bitcoin's movements and upcoming catalysts like energization of Sweetwater facilities. Some traders are also wary of macroeconomic factors and the potential impact of rising interest rates.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending amidst a significant price drop, sparking discussions about potential reasons ranging from AI sector concerns to possible manipulation. Community members are debating dip-buying strategies, speculating on news catalysts, and analyzing technical indicators to gauge potential support levels. The focus remains on the long-term potential of Applied Digital and the data center industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS Does everyone understand the BEST AVAILABLE TREATMENT for the CONTROL ARM Patients is TOXIC As F??? 
in the VIALE- A Trial - 83% suffer Serious Side Effects, and 23% DIED ... DIED from Taking AzaVEN. 
 
$ABBV Terminated the VIALE-M Maintenance Trial for AML Patients in First Remission - even with multiple reduced dosing schedules - its not effective Maintenance for CR1 Patients, its going to be worse for CR2. 
 
- Just like all the KOL&#39;s have STATED - BAT is toxic, MOS is Dismal, extremely poor, not durable - actual QUOTES, just 6 month, 6-8 months, 5-7 months with AZA VEN.

Polsky007

Margaret (Peggy) Murphy

GPs 24 / Control 8

Janulf

TTP222

The Hooking Bull

Bob Didonato

Stan

John-117

Robert

Arturas Paulikas

CMSP

K2 Climber

$SLS The co stated, and restated several times in Aug, Oct and Nov - Phase 3 Results are Expected by the end of Year   
- THIS MONTH . . . and Not much - THIS MONTH, is LEFT.    
   
Dr. Jamy, - &quot;MOS is dismal, just 6 months, 6 to 8 months&quot;   
 - &quot;You will not See survival past 12 months&quot;.   
Dr. Tsirigotis, - &quot;MOS is extremely poor, just 5-7 months&quot;.   
Dr. Levy, - &quot;MOS is not Durable, just 6 months&quot;.  
- these dr&#39;s treat 15% of the Enrolled P3 Trial Patients, and are Saying MOS for Patients on Aza+VEN (Control) is just 6-8 months.  
- We know from the IDMC, Unblinded P3 Interim Data: ALL Pooled MOS was not yet met, and &gt; 13.5 months.  
All Pooled is 6 - 8 combined w GPS (x) = nym &gt;13.5  
GPS (X) solves for nym &gt; 19 months - at the interim, a year ago.

StockTwits Web

SELLAS Life Sciences Group Inc

Abbvie Inc

 Does everyone understand the BEST AVAILABLE TREATMENT for the CONTROL ARM Patients is TOXIC As F??? 
in the VIALE- A Trial - 83% suffer Serious Side Effects, and 23% DIED ... DIED from Taking AzaVEN. 
 


 Terminated the VIALE-M Maintenance Trial for AML Patients in First Remission - even with multiple reduced dosing schedules - its not effective Maintenance for CR1 Patients, its going to be worse for CR2. 
 
- Just like all the KOL's have STATED - BAT is toxic, MOS is Dismal, extremely poor, not durable - actual QUOTES, just 6 month, 6-8 months, 5-7 months with AZA VEN.